"Impinj delivered revenue of $96.1M, topping the $92.63M consensus estimate by 3.7%. More meaningful was the adjusted EBITDA of $19.1M, which exceeded guidance. On a year-over-year basis, revenue inched up just 0.95% to $96.1M from $95.2M, a deceleration that reflects the softer demand environment the company has navigated. The non-GAAP EPS of $0.58 beat the $0.50 estimate by 16%, signaling that cost management and operational efficiency are driving profitability even as topline growth stalls. Operating income swung positive to $656K from a $769K loss in the prior year quarter. This inflection matters because it shows the Gen2X product focus and restructuring efforts are taking hold."
"Operating cash flow nearly doubled year-over-year, rising to $20.9M from $10.1M. Free cash flow reached $17.95M in the quarter. This is the clearest sign that management's operational discipline is translating into tangible cash returns, not just accounting adjustments. Shareholders' equity expanded 43.3% to $195.0M, reflecting both profitability and balance sheet strengthening. The company's cash position declined to $51.7M from $73.1M year-over-year, a 29.8% drop."
Revenue totaled $96.1M, up 0.95% year-over-year and 3.7% above consensus. Adjusted EBITDA reached $19.1M and non-GAAP EPS was $0.58, beating estimates. Operating income moved to a $656K profit from a $769K loss year-over-year. Operating cash flow rose to $20.9M and free cash flow was $17.95M. Shareholders' equity grew 43.3% to $195.0M. Cash decreased to $51.7M from $73.1M, while long-term debt stood at $284.3M. Q4 guidance forecasts revenue of $90.0M–$93.0M and non-GAAP EPS of $0.48–$0.52. Intraday trading rose 2.55%, with a 10% after-hours decline.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]